Suvisto Pharmaceutical (India) Private Limited

Nitroglycerin Controlled Release (CR) Tablets are a cardiovascular medication used for the prevention and long-term management of angina pectoris (chest pain) associated with coronary artery disease. The controlled-release formulation ensures a gradual and sustained release of the drug, providing prolonged therapeutic effect.

Key Features:

• Controlled Release Technology: Delivers nitroglycerin slowly over time for long-lasting action and reduced dosing frequency.

• Vasodilator Action: Relaxes and widens blood vessels, improving blood flow to the heart and reducing cardiac workload.

• Improved Compliance: Maintains stable drug levels in the body, minimizing fluctuations and enhancing patient convenience.

Uses:

• Prevention of angina (chest pain)

• Management of coronary artery disease

• Support in chronic heart-related conditions

Benefits:

• Reduces frequency of angina attacks

• Enhances oxygen supply to heart muscles

• Decreases strain on the heart

• Provides sustained relief due to prolonged action

Mechanism of Action:
Nitroglycerin is converted into nitric oxide in the body, which causes relaxation of vascular smooth muscles, leading to dilation of arteries and veins. This reduces the heart’s oxygen demand and improves circulation.

Directions for Use:

• Take as prescribed by a physician

• Swallow the tablet whole; do not crush or chew

• Follow a regular dosing schedule for best results

Storage:
Store in a cool, dry place below 30°C, away from light and moisture.

Note:
This is a prescription medicine and should be used only under medical supervision. It is not intended for immediate relief of acute chest pain (for that, fast-acting formulations are used).

Stay protected from heart-related risks—use regularly as advised and keep your heart healthy!

Additional Information:

• Production Capacity: As Per Order
• Delivery Time: With in few days
• Packaging Details: Bottle Packing